Two Sigma Securities, LLC
- SEC CIK
- 0001450144
- Latest filing
- Aug 14, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Two Sigma Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −27,654−100.0% | Sold out | Holders |
| Q4 2024 | 27,654 | $25.7K | <0.1% | +9,958+56.3% | Added | Holders |
| Q3 2024 | 17,696 | $23.0K | <0.1% | −3,618−17.0% | Reduced | Holders |
| Q2 2024 | 21,314 | $26.4K | <0.1% | +21,314 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −21,535−100.0% | Sold out | Holders |
| Q4 2023 | 21,535 | $12.2K | <0.1% | +21,535 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −17,701−100.0% | Sold out | Holders |
| Q4 2022 | 17,701 | $40.0K | <0.1% | +4,033+29.5% | Added | Holders |
| Q3 2022 | 13,668 | $44.0K | <0.1% | −11,765−46.3% | Reduced | Holders |
| Q2 2022 | 25,433 | $97.0K | <0.1% | +25,433 | New | Holders |